From result reactions coming from Hindalco, Divi’s Labs, Eicher Motors, JK Cement, Torrent Pharma and many others, to Glenmark settling patent litigations and oil sensitives…
Anupam Rasayan will acquire up to 74.2% stake in Bliss GVS Pharma, strengthening its presence across the pharmaceutical value chain and expanding its reach in…
Marco Rubio’s India visit renewed focus on an India-US trade deal, energy security and Quad cooperation, as experts said both countries are seeking deeper strategic…
JK Cement reported lower fourth-quarter profit as margin pressure offset strong revenue and volume growth, while the company expanded capacity and announced a final dividend…
Precision Wires reported strong Q4FY26 growth with profit rising 45% and revenue climbing over 30%, while the board declared a final dividend and approved fresh…
NTPC reported a stronger-than-expected Q4 profit with net earnings rising 15% year-on-year, while the board declared a final dividend and its green energy arm unveiled…
Sarda Energy reported a sharp rise in fourth-quarter profit and operating margins, with EBITDA growth outpacing revenue expansion as the company rebounded from a softer…
The company said Glenmark USA has denied all allegations and that the settlement “does not constitute any concession or admission of liability, wrongdoing, or illegality”.
Envision Capital founder Nilesh Shah says strong earnings, improving cash flows and long-term structural trends are driving confidence in India’s platform companies. He also highlights…
The board of the Hyderabad-based pharmaceutical company also recommended a final dividend of ₹30 per share for FY26.